Neogen (NEOG) EBT Growth (1y) (2011 - 2026)
Neogen (NEOG) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 17.94% |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | 98.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 98.08% |
| Feb 28, 2026 | -109.28% |
| Nov 30, 2025 | 95.73% |
| Aug 31, 2025 | 380.66% |
| May 31, 2025 | -9,764.20% |
| Feb 28, 2025 | -66.61% |
| Nov 30, 2024 | -12,618.76% |
| Aug 31, 2024 | -1,038.60% |
| May 31, 2024 | -183.65% |
| Feb 29, 2024 | -157.61% |
| Nov 30, 2023 | 89.01% |
| Aug 31, 2023 | -75.03% |
| May 31, 2023 | -59.54% |
| Feb 28, 2023 | -134.02% |
| Nov 30, 2022 | -363.70% |
| Aug 31, 2022 | -69.35% |
| May 31, 2022 | -6.14% |
| Feb 28, 2022 | -58.42% |
| Nov 30, 2021 | -33.14% |
| Aug 31, 2021 | 9.68% |